Conference Dates: May 12, 2003, 6:30-8:30PM
Conference Location: The Wellness Community Philadelphia
Sponsoring Group: GlaxoSmithKline Oncology
Conference Web Page URL: www.twcp.org
Topics Covered: Dr. Christina S. Chu, a gynecologic oncologist from the University of Pennsylvania Health System will provide information about treatment planning for ovarian cancer.
Conference Objectives: To share important treatment planning information
Who Should Attend: Cancer patients and caregivers.
Conference Agenda: Dr. Chu will provide new information about ovarian cancer and the importance of proactively planning the sequence of your treatment for optimal results. Each participant will receive The Wellness Community's "Patient Active Guide to Living with Ovarian Cancer".
Registration Information: Please call 215-879-7733 to register by May 9, 2003.
Conference Fees: Free/ No charge
Continuing Education: No
Feb 25, 2013 - Although patients with invasive ovarian cancer carrying BRCA1/2 mutations have a short-term survival advantage compared with noncarriers, the advantage is short-lived and is no longer observed at 10 years post-diagnosis, according to a study published in the Jan. 16 issue of the Journal of the National Cancer Institute.
Mar 17, 2010
Sep 1, 2014